Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Novartis India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended June 30, 2016
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Fixes Record Date for Buyback
Novartis India Ltd has informed BSE that the Buyback Committee Meeting held on July 12, 2016 fixed July 22, 2016 as the Record Date for the purpose of determining the entitlement and the names of the Shareholders, who are eligible to participate in the Buyback Offer. Fixes Record Date for Final Dividend
Novartis India Ltd has informed BSE that the Company has fixed July 22, 2016 as the record date for the purpose of Payment of Final Dividend. Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Novartis India Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. AGM on July 29, 2016
Novartis India Ltd has informed BSE that the Annual General Meeting (AGM) of the Company will be held on July 29, 2016. Outcome of Board Meeting (Appointment of Additional Director & Whole Time Director)
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 13, 2016, has approved appointment of Ms. Monaz Noble as Additional Director on the Board of Directors of the Company w.e.f June 13, 2016 to hold the office of Additional Director upto the date of Annual General Meeting (AGM).Subject to the approval of Members at the forthcoming AGM, the Board also approved appointment of Ms Monaz... Notice of Postal Ballot
Novartis India Ltd has submitted to BSE a Copy of the Notice of Postal Ballot. Board approves Buyback of equity shares
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2016, (commencement time 11.30 a.m. and conclusion time 6.30 p.m.) unanimously approved a buyback proposal for purchase by the Company of upto 3,820,000 equity shares of Rs. 5/- each (representing 11.95% of the total paid -up equity capital), from all the existing equity shareholders of the Company on the record date on a proportionate basis... Board recommends Dividend
Novartis India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2016, inter alia, has considered and approved the following items:1. Dividend recommendation of Rs. 10/- per equity share of Rs. 5/- each for the year ended March 31, 2016;2. The Board accepted the resignation of Mr. Dinesh Charak as Director and Whole Time Director of the Company from the close of business hours w.e.f. May 26, 2016.